<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all New England Regional Primate Research Center stories</title>
 <link>http://harvardscience.harvard.edu/stories/program/822</link>
 <description>Stories referencing a program (RSS)</description>
 <language>en</language>
<item>
 <title>Brain injury reversed in animal model of AIDS</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/brain-injury-reversed-animal-model-aids</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Depending on the circumstances, missing N-acetylaspartate  (NAA) in the brain may indicate Alzheimer&#039;s disease, ischemic  stroke, a brain tumor, or traumatic injury. And, as doctors soon  learned with the AIDS epidemic, NAA levels drop in tandem with  the neurological deterioration that further cripples people with  HIV.
&lt;p&gt;Yet Gilberto Gonzalez was unprepared for the precipitous fall  and resurgence of this marker of neuronal injury in macaques  with simian immunodeficiency virus (SIV) over the course of their  AIDS-like disease, before and after they were treated with a  potent antiretroviral cocktail.
&lt;p&gt;&quot;We expected a decline, but we saw a whopping decline,&quot; said  Gonzalez, Harvard Medical School professor of radiology and  chief of neuroradiology at Massachusetts General Hospital.  &quot;When we treated them, we expected the decline to stabilize, but  the rebound was as stunning as the decline. I&#039;ve never seen  anything like it.&quot;
&lt;p&gt;The observations suggest that neuronal injury in AIDS - and  perhaps other neurodegenerative diseases - may be reversible  and that treating monocytes in the blood may ameliorate or  prevent the brain damage, Gonzalez and his colleagues reported  in the September 2005 Journal of Clinical Investigation.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 05:41:11 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3555 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Learning how the SARS virus spikes its quarry</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/learning-how-sars-virus-spikes-its-quarry</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Structural images that show how the SARS virus&#039;s spike protein  grasps its receptor may help scientists learn new details about  how the virus infects cells and could also help in identifying  potential weak points that novel drugs or vaccines could exploit.
&lt;p&gt;A worldwide SARS (severe acute respiratory syndrome) outbreak  in 2002-2003 affected more than 8,000 people and killed 774  before being brought under control. Public health experts worry  about another outbreak of the virus, which originates in animals  such as civet cats.
&lt;p&gt;The research team, led by Howard Hughes Medical Institute  investigator Stephen C. Harrison at Children&#039;s Hospital and  Harvard Medical School, and colleague Michael Farzan, also at  Harvard Medical School, reported its findings in the September  16, 2005 issue of the journal Science.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 06:21:52 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3688 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
